Extrahepatic recurrence rates in patients receiving adjuvant hepatic artery infusion and systemic chemotherapy after complete resection of colorectal liver metastases.

Rami M SroujiRaja R NarayanThomas BoernerFlorian E BuismanKenneth SeierMithat GonenVinod P BalachandranJeffrey A DrebinWilliam R JarnaginThomas Peter KinghamAlice WeiNancy E KemenyMichael I D'Angelica

Published in: Journal of surgical oncology (2020)

Despite the reduced dose of SYS, adjuvant HAI + SYS after CRLM resection is not associated with a significantly increased risk of extrahepatic recurrence.

Keyphrases

liver metastases
early stage
free survival
low dose
locally advanced
rectal cancer
chemotherapy induced